United States v. Williams ( 1997 )


Menu:
  • UNPUBLISHED
    UNITED STATES COURT OF APPEALS
    FOR THE FOURTH CIRCUIT
    UNITED STATES OF AMERICA,
    Plaintiff-Appellee,
    v.                                                                 No. 95-5886
    MARGARET VIOLET JENKINS WILLIAMS,
    Defendant-Appellant.
    UNITED STATES OF AMERICA,
    Plaintiff-Appellee,
    v.                                                                 No. 95-5900
    KENNETH HATALA,
    Defendant-Appellant.
    Appeals from the United States District Court
    for the Northern District of West Virginia, at Clarksburg.
    Irene M. Keeley, District Judge.
    (CR-95-2)
    Submitted: February 27, 1997
    Decided: March 19, 1997
    Before MURNAGHAN, NIEMEYER, AND MOTZ, Circuit Judges.
    _________________________________________________________________
    Affirmed by unpublished per curiam opinion.
    _________________________________________________________________
    COUNSEL
    R. Mike Mullens, Elkins, West Virginia; Hunt L. Charach, Federal
    Public Defender, C. Cooper Fulton, Assistant Federal Public
    Defender, Charleston, West Virginia, for Appellants. William D. Wil-
    moth, United States Attorney, Paul T. Camilletti, Assistant United
    States Attorney, Wheeling, West Virginia, for Appellee.
    _________________________________________________________________
    Unpublished opinions are not binding precedent in this circuit. See
    Local Rule 36(c).
    _________________________________________________________________
    OPINION
    PER CURIAM:
    Margaret Jenkins Williams and Kenneth Hatala entered guilty pleas
    to Count One of a ten-count indictment charging them with conspir-
    acy to possess with intent to distribute and to distribute dilaudid
    (hydromorphone), 
    21 U.S.C. § 846
     (1994), and related offenses. They
    appeal their sentences. We affirm.
    Between 1989 and 1994, Margaret Williams sought treatment for
    leukemia from at least nine doctors, claiming that she had discontin-
    ued chemotherapy for the disease and wanted simply to be free from
    pain until she died. To many of the doctors, she provided altered cop-
    ies of her medical records. She obtained prescriptions for 6985
    dilaudid tablets in this way. Some of the dilaudids were used by Wil-
    liams' son, Kenneth Hatala, and her daughter, Elizabeth Jenkins. The
    majority of them were sold by Hatala, Jenkins, Williams, and her hus-
    band, Emerson Herrod. They often accepted stolen property as pay-
    ment, and Williams eventually rented a storage unit in which to keep
    the overflow of stolen items. Herrod transported Williams to various
    doctors and had the prescriptions filled for her. Four days before their
    joint trial was scheduled, the defendants entered guilty pleas.
    I. Drug Amount
    Williams and Hatala were sentenced separately; both contest the
    district court's determination of the amount of drugs for which they
    2
    were accountable. The court's decision is reviewed for clear error.
    United States v. McDonald, 
    61 F.3d 248
    , 255 (4th Cir. 1995).
    Appellants challenge the district court's use of all 6985 dilaudid
    tablets to calculate their offense levels pursuant to USSG § 2D1.1.1
    Both argued unsuccessfully in the district court that the amount
    should be reduced by the number of dilaudids consumed by the con-
    spirators because the government had not shown specific intent to dis-
    tribute those tablets. The district court discounted Herrod's and
    Williams' assertions at Williams' sentencing that she took between
    two and four dilaudids a day during the conspiracy 2 because Williams
    showed no sign of dilaudid addiction while she was in custody and
    never tested positive for dilaudid use while she was on release. More-
    over, Betty Atkins, a friend of Jenkins who lived in Williams' house
    for several years, testified that the only time Williams used dilaudid
    was just before she went to a doctor, so that the drug would be in her
    system if she were tested. While Hatala and Jenkins were known to
    be users of dilaudid, the court found that any amounts they consumed
    were properly included as relevant conduct.
    The Ninth Circuit has held that drugs possessed for personal use
    are not part of the same course of conduct or common scheme as
    drugs possessed with intent to distribute, and thus are not relevant
    conduct for sentencing under USSG § 1B1.3(a)(2). See United States
    v. Rodriguez-Sanchez, 
    23 F.3d 1488
    , 1494-96 (9th Cir. 1994); United
    States v. Kipp, 
    10 F.3d 1463
    , 1465-66 (9th Cir. 1993). However, other
    circuits have held to the contrary. See United States v. Antonietti, 
    86 F.3d 206
    , 209 (11th Cir. 1996) (purchases for personal use are rele-
    vant conduct in determining amount defendant knew were distributed
    by conspiracy); accord United States v. Fregoso , 
    60 F.3d 1314
    , 1328
    (8th Cir. 1995); United States v. Snook, 
    60 F.3d 394
    , 395 (7th Cir.
    1995); United States v. Wood, 
    57 F.3d 913
    , 920 (10th Cir. 1995). The
    weight of authority persuades us that the district court did not clearly
    _________________________________________________________________
    1 United States Sentencing Commission, Guidelines Manual (Nov.
    1995).
    2 Four tablets a day during the course of the conspiracy would have
    amounted to more than the total amount which Williams was known to
    have obtained.
    3
    err in finding that the total number of dilaudid obtained with fraudu-
    lently obtained prescriptions was relevant conduct for each defendant.
    Williams also argued that Kenneth Hatala's girlfriend, Donna
    Koval, used Williams' name to forge prescriptions without her knowl-
    edge, and that her relevant conduct should be reduced accordingly.
    However, Williams was held accountable for the number of dilaudid
    tablets for which she personally obtained prescriptions, as shown by
    the records of the doctors and the pharmacies which issued and filled
    the prescriptions. She was not held accountable for the additional 340
    dilaudid tablets which Hatala and Koval obtained without Williams'
    knowledge; this number was added only to Hatala's relevant conduct.
    The court also reduced Hatala's relevant conduct by the number of
    tablets obtained during periods when he was incarcerated in Florida
    and in West Virginia. However, the court found that he was responsi-
    ble for dilaudids obtained during a period when he was employed in
    Florida but returned to West Virginia regularly to sell tablets for his
    mother. In sum, we find that the district court's determination of the
    base offense level for each defendant was not clearly erroneous.
    II. Acceptance of Responsibility
    Williams contends that the district court clearly erred when it
    refused to award her an adjustment for acceptance of responsibility.
    USSG § 3E1.1. She argues that she earned the adjustment by negoti-
    ating a plea shortly after she received copies of statements made by
    witnesses the government expected to call at trial (the Jencks materi-
    als). She also asserts that she was prevented from cooperating earlier
    because the government would not consider a plea from one defen-
    dant unless all agreed to plead guilty.
    Williams admitted lying to the doctors to obtain dilaudid but
    blamed her children and their friends for convincing her to pretend
    that she had cancer. Because information from many sources indi-
    cated that Williams was the driving force in the conspiracy, the dis-
    trict court found that she was attempting to downplay her involvement
    rather than making a truthful admission of her criminal conduct. We
    find that the district court did not clearly err in finding that she had
    not demonstrated acceptance of responsibility.
    4
    III. Leadership Role (Williams)
    Williams testified at her sentencing that her children took advan-
    tage of her ability to get prescriptions for dilaudid. She disclaimed
    knowledge or responsibility for sale of the tablets, although she did
    acknowledge selling a few of them. She said she got no money from
    the sales and claimed that she took between one and four dilaudid a
    day. Based on Atkins' testimony, however, the district court found
    that Williams was the organizer and leader of a conspiracy which,
    including her customers, comprised more than five participants.
    USSG § 3B1.1(a). The court's conclusion is supported by information
    received during the investigation from Donna Koval and a number of
    people who purchased dilaudid from Williams or her family. The
    court did not clearly err in making the adjustment.
    IV. Obstruction of Justice (Hatala)
    Hatala encountered Ray Cate, a defendant in a related case, while
    both were incarcerated, and told Cate that he would kill anyone who
    testified against him and would kill the witness's family if he could
    not get to the witness. Cate was not included on the government's
    witness lists prior to Hatala's plea. Hatala argued that the threat did
    not warrant an adjustment for obstruction of justice because Cate was
    neither a co-defendant, a witness, or a juror in his case. See USSG
    § 3C1.1, comment. (n.3(a)) (listing examples of obstructive conduct).
    The district court found that Hatala viewed Cate as a potential witness
    and made the threat to prevent him from testifying. We agree that the
    threat was an attempt to obstruct justice and such conduct merits an
    increase under the guideline. The district court did not clearly err in
    making the adjustment.
    Accordingly, we affirm the sentences imposed on Williams and
    Hatala. We interpret Williams' motion for appointment of counsel as
    a request for new counsel. Her motion is denied. We dispense with
    oral argument because the facts and legal contentions are adequately
    presented in the materials before the court and argument would not
    aid the decisional process.
    AFFIRMED
    5